Identification of antimalarial drugs and bradykinin as ligands of the Plasmodium membrane protein PfSR10
Year: 2025
Type: article
Abstract: are potential drug targets and may contribute to pathophysiological processes in malaria. Recent studies show that the serpentine receptor SR10 is essential for coordinating host rhythms during parasite development. In this study, we found that antimalarial drugs including chloroquine (CQ), dihydroartemisinin (DHA), piperaquine-tetraphosphatetetrahydrate (PIP-TT), and primaquine diphosphate (PQ) are PfSR10 agonists that induce coupling with human Gi/Gq proteins, confirmed through biochemical reconstitution and cryo-EM analysis. Using proteomic profiling, we also identified bradykinin as an endogenous agonist activating PfSR10. Ligand binding and conformational changes were characterized via mutagenesis and FlAsH-BRET assays. These results establish PfSR10 as a receptor for both antimalarials and host peptides, highlighting its dual role in drug action and host-parasite communication, with broad implications in understanding malaria pathogenesis and developing new therapeutics.
Source: iScience
Authors: Dan Jiang, Xin Wen, Ji-Fei Han, Qiu-Xia Cheng, Ru Zhang, Yuan Zheng, Kai Zheng, Shao-Hui Huang, Jia-Yuan Chen, Su-Wen Li, Zhi-Shuai Yang, Bing Han, Lu Tie, Fan Yang, Peng-Ju Zhang, Peng Xiao, Hui Lin, Xiao Yu, Jin-Peng Sun
Language: English
Topic: Malaria Research and Control
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,240
Funders: Shandong University, National Natural Science Foundation of China, Natural Science Foundation of Shandong Province, Taishan Scholar Foundation of Shandong Province, National Outstanding Youth Science Fund Project of National Natural Science Foundation of China, Natural Science Fund for Distinguished Young Scholars of Shandong Province, China National Funds for Distinguished Young Scientists, National Key Research and Development Program of China, National Science Fund for Distinguished Young Scholars
OpenAlex ID: W4415424823
